DSN28369

• CAT Number: I026564
• CAS Number: 2413428-36-9
• Molecular Formula: C25H31N5O8
• Molecular Weight: 529.55
• Purity: 98%
• Synonyms: DSN28369; DSN-28369; DSN 28369
• Target: ADC Linker
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 2-[[(2S)-2-[[2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]acetic acid
• InChI: InChI=1S/C25H31N5O8/c31-19(9-5-2-6-12-30-22(34)10-11-23(30)35)26-14-20(32)27-15-21(33)29-18(25(38)28-16-24(36)37)13-17-7-3-1-4-8-17/h1,3-4,7-8,10-11,18H,2,5-6,9,12-16H2,(H,26,31)(H,27,32)(H,28,38)(H,29,33)(H,36,37)/t18-/m0/s1
• InChIKey: DWPLKZYCOGLRPC-SFHVURJKSA-N
• SMILES: C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)O)NC(=O)CNC(=O)CNC(=O)CCCCCN2C(=O)C=CC2=O

DSN28369（Cat No.:I026564）is an investigational small molecule compound being studied for its potential therapeutic applications in cancer treatment. It acts as a selective inhibitor of the protein kinase casein kinase 2 (CK2), an enzyme involved in various cellular processes, including cell survival, proliferation, and apoptosis. Overexpression or dysregulation of CK2 has been linked to the development and progression of several cancers. By inhibiting CK2, DSN28369 aims to suppress tumor growth and enhance the effectiveness of existing cancer therapies. Preclinical studies are ongoing to evaluate its anticancer efficacy, pharmacokinetics, and safety in clinical settings.